Literature DB >> 9456214

Sensitivity analysis and the expected value of perfect information.

J C Felli1, G B Hazen.   

Abstract

Measures of decision sensitivity that have been applied to medical decision problems were examined. Traditional threshold proximity methods have recently been supplemented by probabilistic sensitivity analysis, and by entropy-based measures of sensitivity. The authors propose a fourth measure based upon the expected value of perfect information (EVPI), which they believe superior both methodologically and pragmatically. Both the traditional and the newly suggested sensitivity measures focus entirely on the likelihood of decision change without attention to corresponding changes in payoff, which are often small. Consequently, these measures can dramatically overstate problem sensitivity. EVPI, on the other hand, incorporates both the probability of a decision change and the marginal benefit of such a change into a single measure, and therefore provides a superior picture of problem sensitivity. To lend support to this contention, the authors revisit three problems from the literature and compare the results of sensitivity analyses using probabilistic, entropy-based, and EVPI-based measures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9456214     DOI: 10.1177/0272989X9801800117

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  38 in total

Review 1.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

2.  Sensitivity analysis for healthcare models fitted to data by statistical methods.

Authors:  Rose D Baker
Journal:  Health Care Manag Sci       Date:  2002-11

3.  Treating mild gestational diabetes mellitus: a cost-effectiveness analysis.

Authors:  Mika S Ohno; Teresa N Sparks; Yvonne W Cheng; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2011-06-21       Impact factor: 8.661

4.  Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Hyon K Choi; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

5.  Decision-analytic modeling to assist decision making in organizational innovation: the case of shared care in hearing aid provision.

Authors:  Janneke P C Grutters; Manuela A Joore; Frans Van Der Horst; Robert J Stokroos; Lucien J C Anteunis
Journal:  Health Serv Res       Date:  2008-06-03       Impact factor: 3.402

6.  "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier.

Authors:  Fernando Alarid-Escudero; Eva A Enns; Karen M Kuntz; Tzeyu L Michaud; Hawre Jalal
Journal:  Value Health       Date:  2019-05       Impact factor: 5.725

7.  Exploring uncertainty in cost-effectiveness analysis.

Authors:  Karl Claxton
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes.

Authors:  Gianluca Baio; Pierluigi Russo
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

Authors:  Hawre Jalal; Jeremy D Goldhaber-Fiebert; Karen M Kuntz
Journal:  Med Decis Making       Date:  2015-04-03       Impact factor: 2.583

10.  Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.

Authors:  Anna Heath; Natalia Kunst; Christopher Jackson; Mark Strong; Fernando Alarid-Escudero; Jeremy D Goldhaber-Fiebert; Gianluca Baio; Nicolas A Menzies; Hawre Jalal
Journal:  Med Decis Making       Date:  2020-04-16       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.